Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

This study found that autologous platelet-rich plasma increased hair growth potential by enhancing dermal papilla cell proliferation and stimulating key signaling pathways in both cell cultures and mice models.

This review evaluates various kits for isolating platelet-rich plasma using established processing standards and finds they enable compliance with consensus quality criteria; ongoing research is needed to refine these procedures for improved consistency and safety.

This review discusses the use of platelet-rich plasma for pattern hair loss treatment and examines existing clinical studies without presenting new clinical results.

This review explores the variability in platelet-rich plasma therapy outcomes across different medical applications, attributing disparities to inconsistent blood processing methods, and it reports no new clinical results.

This small study observed that infusing platelet rich plasma into the scalp reversed hair miniaturization and stimulated new hair growth in patients with androgenetic alopecia and alopecia areata over 8 months.

This study found that intraovarian PRP treatment in women with low ovarian reserve was associated with significant increases in serum AMH levels in some patients, typically within four weeks.

This abstract describes the components found in the alpha and dense granules of platelets, but it provides no new research findings.

This study found that autologous platelet-rich plasma was associated with increased hair density in people with pattern hair loss, but with considerable variability and unclear risks of bias.

This study developed a simple method to prepare highly concentrated, resting platelet-rich plasma suitable for cell therapy, effectively preventing clotting while maintaining platelet reactivity and minimizing hemorrhage risk.

Platelet-rich plasma (PRP) may help promote hair growth and improve graft survival after hair transplantation, but more research is needed to confirm its effectiveness and determine the best dosage.

In this study, the direct cost of producing autologous platelet rich plasma gel in a Rio de Janeiro university hospital was found to be US $4.88 per session, highlighting its potential as a low-cost and accessible treatment option within the Unified Health System.

This study observed a slight improvement in hair density in men with androgenetic alopecia treated with autologous platelet rich plasma, but only two cases showed cosmetic improvement.

This abstract provides an overview of the importance of using reliable and valid information for evidence-based medicine, without presenting new experimental results.

In this observational study, the combination of PRP and 5% minoxidil was more effective than minoxidil alone in promoting hair growth in men with androgenetic alopecia.

This study found that autologous platelet rich plasma (PRP) may be a safe and effective treatment for limited alopecia areata, with varying levels of hair regrowth observed among patients.

This review discusses the use and mechanisms of platelet-rich plasma therapy and highlights the need for standardized preparation and application protocols, without reporting new clinical results.

Combining UV therapy with PRP heals chronic wounds faster and reduces pain.

This study found that the cross-section trichometer (HairCheck device) can accurately and sensitively measure hair mass index changes, offering a convenient tool for assessing hair density and diameter in patients with alopecia.

This randomized prospective study found that microneedling combined with autologous platelet-rich plasma resulted in significant hair regrowth and reduction in SALT score after 12 weeks in patients with chronic and stable alopecia areata, suggesting it as a safe and efficient treatment option.

This review analyzes studies on autologous platelet-rich plasma for androgenic alopecia, reporting mixed results and highlighting the need for standardized protocols and further research.

The study concluded that the Exprecell™ device for preparing anticoagulant-free f-PRF increases volume yield and simplifies the process while maintaining biological activity comparable to conventional methods, suggesting potential clinical utility.

This review synthesizes existing research on autologous platelet-rich plasma for treating androgenetic alopecia, suggesting its promise with standardized protocols and personalized approaches, but reports no new clinical results.

This study found that platelet-rich plasma therapy significantly improved hair density and reduced hair shedding in Vietnamese patients with androgenetic alopecia, with high patient satisfaction and minimal side effects.

This literature review highlights the widespread use of platelet-rich plasma in medicine but notes inconclusive evidence for its clinical efficacy due to specimen variability and unresolved methodological issues.

In this study, researchers found that autologous platelet-rich plasma injections significantly improved hair density and patient satisfaction in both male and female patients with androgenetic alopecia, with no major side effects reported.

This study found that injecting autologous PRP significantly reduced the healing time of superficial wound dehiscence after Pfannenstiel incision surgery to an average of 15.80 days, compared to 20.30 days for conventional wound care alone.

PRP injections can increase hair density in people with androgenic alopecia.

This study concluded that monthly intralesional autologous platelet-rich plasma therapy significantly decreased alopecia areata severity over four months compared to daily 5% topical minoxidil therapy.

This abstract highlights the prevalence of androgenetic alopecia in men and young adults and mentions the psychological impact, noting that while various therapies exist, clear treatment algorithms are lacking according to this source.